FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy--tumor volume and FDG uptake value.

[1]  T. Yen,et al.  Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow‐up for patients with cervical malignancies , 2004, Cancer.

[2]  J. Unger,et al.  Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women. , 2004, Gynecologic oncology.

[3]  Imran Zoberi,et al.  Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  T. Yen,et al.  Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT. , 2004, International journal of radiation oncology, biology, physics.

[5]  T. Yen,et al.  Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  A. Berchuck,et al.  The role of PET scanning in the detection of recurrent cervical cancer. , 2003, Gynecologic oncology.

[7]  Y. Hung,et al.  Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings. , 2003, Gynecologic oncology.

[8]  C. Choi,et al.  Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  L. Kostakoglu,et al.  18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  P. Grigsby,et al.  FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma. , 2002, International journal of radiation oncology, biology, physics.

[11]  P. Rigo,et al.  Contribution of Whole-Body 18FDG PET Imaging in the Management of Cervical Cancer , 2002 .

[12]  H. Ishikawa,et al.  Analysis of recurrence of squamous cell carcinoma of the uterine cervix after definitive radiation therapy alone: patterns of recurrence, latent periods, and prognosis. , 2001, International journal of radiation oncology, biology, physics.

[13]  S. Sun,et al.  Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer. , 2001, Anticancer research.

[14]  T. Akimoto,et al.  Radiation therapy for elderly patient with squamous cell carcinoma of the uterine cervix. , 2000, Gynecologic oncology.

[15]  D. Mankoff,et al.  Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  H. Sakurai,et al.  Results of postoperative radiation therapy for patients with carcinoma of the uterine cervix: evaluation of intravaginal cone boost with an electron beam. , 1995, Gynecologic oncology.

[17]  H. Sakurai,et al.  Squamous cell carcinoma of the uterine cervix: radiation therapy for patients aged 70 years and older. , 1995, Radiology.

[18]  P. Grigsby,et al.  Distant metastases after irradiation alone in carcinoma of the uterine cervix. , 1992, International journal of radiation oncology, biology, physics.

[19]  L G Strauss,et al.  The applications of PET in clinical oncology. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  L. Brady,et al.  Failure patterns in gynecologic cancer. , 1986, International journal of radiation oncology, biology, physics.

[21]  J. Purdy,et al.  Radiation therapy alone in the treatment of carcinoma of uterine cervix I. Analysis of tumor recurrence , 1983, Cancer.